Carnegie Mellon University
The goal of this clinical trial is to evaluate the feasibility of a prototype artificial intelligence (AI)-based controller for a lightweight hip exoskeleton across a broad range of users, including healthy younger adults (18-39 years) and older adults (65 years and older). The main questions it aims to answer are: * Can the AI-based controller accurately estimate gait phase in real time across younger and older adults? * How does hip exoskeleton assistance change walking energy cost, mechanics, and muscle activity? Researchers will compare walking with powered hip exoskeleton assistance to walking without the exoskeleton and walking while wearing the exoskeleton with no assistance (zero torque). Participants will: * Complete a short screening and frailty assessment * Walk on a treadmill under different conditions with and without the hip exoskeleton during 2 to 5 lab visits * Wear motion capture markers, muscle activity (EMG) sensors, and a mask that measures breathing to estimate energy use
This study is funded by the National Institute of Biomedical Imaging and Bioengineering (R21EB037268) and conducted at the University of Texas at Austin in collaboration with Carnegie Mellon University. The CMU Hip Exoskeleton is a research prototype with powered hip joints for flexion and extension (peak torque 18 Nm, total weight 3.5 kg). Its controller uses joint angle and user-state estimates to command assistive torque, limited to less than 0.2 Nm/kg (at most about 30% of typical biological hip moments during walking), so it supplements rather than overrides the user's own muscle effort.…
Inclusion Criteria: * Age 18 to 39 years (younger adult group) or 65 years and older (older adult group) * Willing and able to provide informed consent * Able to walk independently without assistance * No known cardiovascular, metabolic, or renal disease, and no signs or symptoms suggestive of such disease * Cleared for light- to moderate-intensity exercise without the need for medical clearance under American College of Sports Medicine (ACSM) preparticipation screening guidelines Exclusion Criteria: * Age 40 to 64 years * Leg surgery within the past 5 years * Orthopedic disability that cou…
A lightweight (3.5 kg) research hip exoskeleton developed at Carnegie Mellon University with powered hip flexion/extension joints, a backpack-mounted computer and battery, and thigh and waist interfaces secured with straps. An AI-driven controller estimates the user's gait state from joint angle and wearable sensor data and commands assistive hip torque in real time, limited to \<0.2 Nm/kg (peak device torque 18 Nm). Participants walk on a treadmill with powered assistance, with the device worn at zero torque, and without the device. The device was determined by the UT Austin IRB to be a non-significant risk device.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.